Enanta Pharmaceuticals Inc (ENTA)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | 5.826 | 19.425 | 10.261 | -7.412 | -17.082 | -29.908 | -31.949 | -27.665 |
| Return on Equity (%) | 6.197 | 20.696 | 10.835 | -7.879 | -18.478 | -33.785 | -49.739 | -67.166 |
| Return on Invested Capital (%) | 6.801 | 22.771 | 9.962 | -10.598 | -22.745 | -42.725 | -56.084 | -71.117 |
| Operating Margin (%) | 26.248 | 45.068 | 22.202 | -28.593 | -110.822 | -141.815 | -158.89 | -157.977 |
| Net Profit Margin (%) | 17.225 | 34.824 | 22.604 | -29.531 | -81.377 | -141.313 | -168.951 | -171.575 |
| Book Value Per Share | 15.778 | 20.298 | 23.473 | 22.692 | 19.737 | 15.508 | 10.294 | 6.08 |
| Earnings Per Share | 0.926 | 3.71 | 2.354 | -1.801 | -3.903 | -5.876 | -6.356 | -5.477 |
| Cash Per Share | 3.435 | 3.295 | 2.6 | 4.34 | 2.827 | 2.123 | 4.055 | 1.757 |
| Working Capital Per Share | 11.341 | 18.786 | 19.248 | 20.555 | 13.976 | 13.605 | 17.098 | 11.437 |
| Operating Profit Per Share | 5.377 | 10.654 | 10.415 | 6.1 | 4.797 | 4.158 | 3.762 | 3.192 |
| EBIT Per Share | 1.409 | 4.801 | 2.312 | -1.744 | -5.316 | -5.897 | -6.222 | -5.559 |
| EBITDA Per Share | 1.409 | 4.801 | 2.312 | -1.744 | -5.316 | -5.897 | -6.222 | -5.559 |
| Free Cash Flow Per Share | 0.946 | 3.734 | 2.464 | -1.911 | -4.031 | -5.917 | -6.038 | -4.74 |
| Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 19.12M | 19.4M | 19.7M | 20.08M | 20.24M | N/A | N/A | N/A |
| Year End September 29 2024 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 20.88M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | -123.044 | N/A | N/A | N/A | -169.905 | N/A | N/A | N/A |
| Net Profit Margin (%) | -122.9 | N/A | N/A | N/A | -185.564 | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 105.12M |
| Price to Earnings Ratio | -0.89 |
| Price to Sales Ratio | 1.54 |
| Price to Cash Ratio | 2.79 |
| Price to Book Ratio | 0.81 |
| Dividend Yield | - |
| Shares Outstanding | 21.19M |
| Average Volume (1 week) | 315.44k |
| Average Volume (1 Month) | 464.01k |
| 52 Week Change | -60.89% |
| 52 Week High | 17.80 |
| 52 Week Low | 4.71 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
